MAINTENANCE RITUXIMAB IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA PATIENTS RESPONDING TO INDUCTION THERAPY WITH BENDAMUSTINE + RITUXIMAB (BR)

Saved in:

Bibliographic Details
Published in:	Hematological oncology Vol. 37; no. S2; pp. 405 - 407
Main Authors:	Hill, B.T., Switchenko, J.M., Martin, P., Churnetski, M.C., Sawalha, Y., Goyal, S., Shanmugasundaram, K., Calzada, O., Kolla, B., Bachanova, V., Gerson, J.N., Barta, S.K., Maldonado, E., Gordon, M., Danilov, A., Grover, N.S., Mathews, S., Burkart, M., Karmali, R., Ghosh, N., Park, S.I., Epperla, N., Bond, D.A., Badar, T., Blum, K.A., Guo, J., Hamadani, M., Fenske, T.S., Malecek, M., Maddocks, K., Flowers, C.R., Kahl, B.S., Cohen, J.B.
Format:	Journal Article
Language:	English
Published:	Chichester Wiley Subscription Services, Inc 01-06-2019
Subjects:	Cell survival Immunotherapy Induction therapy Lymphoma Mantle cell lymphoma Monoclonal antibodies Rituximab Targeted cancer therapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0278-0232 1099-1069
DOI:	10.1002/hon.75_2631